Oncimmune Holdings plc (LON:ONC – Get Free Report)’s stock price reached a new 52-week low on Friday . The company traded as low as GBX 9.75 ($0.12) and last traded at GBX 10 ($0.13), with a volume of 280092 shares traded. The stock had previously closed at GBX 10.50 ($0.13).
Oncimmune Stock Performance
The company has a market cap of £7.41 million, a price-to-earnings ratio of -350.00 and a beta of 1.09. The company has a debt-to-equity ratio of 806.85, a quick ratio of 0.63 and a current ratio of 3.91. The stock’s fifty day simple moving average is GBX 19.05 and its two-hundred day simple moving average is GBX 21.89.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Recommended Stories
- Five stocks we like better than Oncimmune
- How to Use Stock Screeners to Find Stocks
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- How to Capture the Benefits of Dividend Increases
- Qualcomm Stock Continues to Rise in the Face of Negative News
- What is Short Interest? How to Use It
- Top 3 Summer Stocks with Solid Growth Opportunities
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
